Back to Search Start Over

Polyalthic Acid from Copaifera lucens Demonstrates Anticariogenic and Antiparasitic Properties for Safe Use.

Authors :
Santiago, Mariana B.
dos Santos, Vinicius Cristian O.
Teixeira, Samuel C.
Silva, Nagela B. S.
de Oliveira, Pollyanna F.
Ozelin, Saulo D.
Furtado, Ricardo A.
Tavares, Denise C.
Ambrósio, Sergio Ricardo
Veneziani, Rodrigo Cassio S.
Ferro, Eloisa Amália V.
Bastos, Jairo K.
Martins, Carlos Henrique G.
Source :
Pharmaceuticals (14248247); Oct2023, Vol. 16 Issue 10, p1357, 19p
Publication Year :
2023

Abstract

This study aimed at evaluating the potential of Copaifera lucens, specifically its oleoresin (CLO), extract (CECL), and the compound ent-polyalthic acid (PA), in combating caries and toxoplasmosis, while also assessing its toxicity. The study involved multiple assessments, including determining the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) against cariogenic bacteria. CLO and PA exhibited MIC and MBC values ranging from 25 to 50 μg/mL, whereas CECL showed values equal to or exceeding 400 μg/mL. PA also displayed antibiofilm activity with minimum inhibitory concentration of biofilm (MICB<subscript>50</subscript>) values spanning from 62.5 to 1000 μg/mL. Moreover, PA effectively hindered the intracellular proliferation of Toxoplasma gondii at 64 μg/mL, even after 24 h without treatment. Toxicological evaluations included in vitro tests on V79 cells, where concentrations ranged from 78.1 to 1250 μg/mL of PA reduced colony formation. Additionally, using the Caenorhabditis elegans model, the lethal concentration (LC<subscript>50</subscript>) of PA was determined as 1000 μg/mL after 48 h of incubation. Notably, no significant differences in micronucleus induction and the NDI were observed in cultures treated with 10, 20, or 40 μg/mL of CLO. These findings underscore the safety profile of CLO and PA, highlighting their potential as alternative treatments for caries and toxoplasmosis. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14248247
Volume :
16
Issue :
10
Database :
Complementary Index
Journal :
Pharmaceuticals (14248247)
Publication Type :
Academic Journal
Accession number :
173317766
Full Text :
https://doi.org/10.3390/ph16101357